Wells Pharma Of Houston Llc: Fentanyl Citrate Injectable Solution In 0.9% Sodium Chloride, 50 Mcg/5ml)(10 Mcg Per Ml), Wells Pharma
Recall Summary Wells Pharma of Houston LLC is recalling fentanyl citrate injectable solution (50 mcg/5mL vials) distributed nationwide because the product was manufactured with deviations from required quality and safety standards. The recall affects this specific fentanyl product with NDC number 73702-202-15 that was distributed across all U.S. states. Healthcare facilities and pharmacies that received this medication should identify affected units.
- Recalling firm
- Wells Pharma of Houston LLC
- Product
- fentaNYL Citrate Injectable Solution in 0.9% Sodium Chloride, 50 mcg/5mL)(10 mcg per mL), wells pharma, NDC 73702-202-15.
- Reason
- cGMP deviations.
- Classification
- Class II
- Category
- drug recall
- Country
- United States
- Agency
- U.S. Food and Drug Administration
- Recall date
- 2026-04-01
- Status
- Ongoing
- Areas affected
- AL, AK, AZ, AR, CA, CO, CT, DE, FL, GA, HI, ID, ...
- Distribution
- U.S. Nationwide.
Official recall notice from U.S. Food and Drug Administration
Recall details on Nibble Recalls: https://trynibble.app/recalls/53d85720-f2e6-45ad-bb7d-0d7e6378e218